OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis. (Q42277253)
Jump to navigation
Jump to search
scientific article published on 26 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis. |
scientific article published on 26 January 2013 |
Statements
OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis (English)
David Pariser
Paul S Yamauchi
Alan Menter
Craig F Teller
Yifei Shi
Mellissa Yong
Kara Creamer
Michele Hooper
Girish Aras
Gregory Kricorian
26 January 2013